Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 1
1946 3
1947 2
1948 9
1949 4
1950 6
1951 9
1952 4
1953 8
1954 5
1955 3
1956 1
1957 5
1958 6
1959 5
1960 5
1961 10
1962 8
1963 9
1964 15
1965 18
1966 20
1967 37
1968 22
1969 16
1970 18
1971 9
1972 12
1973 9
1974 8
1975 23
1976 20
1977 26
1978 24
1979 23
1980 37
1981 26
1982 40
1983 35
1984 38
1985 58
1986 43
1987 47
1988 59
1989 64
1990 57
1991 57
1992 63
1993 70
1994 64
1995 65
1996 82
1997 81
1998 78
1999 77
2000 91
2001 85
2002 94
2003 91
2004 92
2005 109
2006 133
2007 188
2008 195
2009 219
2010 228
2011 289
2012 308
2013 316
2014 292
2015 277
2016 334
2017 336
2018 345
2019 369
2020 417
2021 448
2022 441
2023 368
2024 403
2025 316
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,514 results

Results by year

Filters applied: . Clear all
Page 1
Skincare ingredients recommended by cosmetic dermatologists: A Delphi consensus study.
Alvarez GV, Kang BY, Richmond AM, Hoss E, Sulewski R, Minkis K, Rozenberg SS, Antonovich D, Boucher A, Bernstein EF, Bertucci V, Chapas AM, Cohen JL, Council ML, Dover JS, Geronemus R, Given KML, Goldbach HS, Goldman MP, Hooper D, Kaufman J, Munavalli G, Pacheco TR, Rossi AM, Wilson S, Alam M. Alvarez GV, et al. Among authors: rossi am. J Am Acad Dermatol. 2025 Apr 14:S0190-9622(25)00612-7. doi: 10.1016/j.jaad.2025.04.021. Online ahead of print. J Am Acad Dermatol. 2025. PMID: 40233838
Extramammary Paget disease. Part II. Evidence-based approach to management.
Shah RR, Shah K, Wilson BN, Leitao MM, Smogorzewski J, Nguyen KA, Crane C, Funt SA, Hosein S, Dafinone M, Rossi A. Shah RR, et al. Among authors: rossi a. J Am Acad Dermatol. 2024 Sep;91(3):421-430. doi: 10.1016/j.jaad.2023.07.1052. Epub 2024 Apr 6. J Am Acad Dermatol. 2024. PMID: 38588817 Review.
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.
Yamshon S, Koff JL, Larson MC, Kahl BS, Casulo C, Lossos IS, Haddadi S, Stanchina M, Chihara D, Ayers A, Habermann TM, Wang Y, Khurana A, Nowakowski GS, Reicks TW, Farooq U, Link BK, Cohen JB, Martin P, Li J, Shewade A, Batlevi CL, Lo-Rossi A, Fox D, Masaquel A, Mun Y, Cerhan JR, Flowers CR, Maurer MJ, Nastoupil LJ. Yamshon S, et al. Among authors: lo rossi a. Am J Hematol. 2025 Apr;100(4):606-615. doi: 10.1002/ajh.27630. Epub 2025 Feb 7. Am J Hematol. 2025. PMID: 39918101
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.
Campione E, Artosi F, Shumak RG, Giunta A, Argenziano G, Assorgi C, Balato A, Bernardini N, Brunasso AMG, Burlando M, Caldarola G, Campanati A, Carugno A, Castelli F, Conti A, Costanzo A, Cuccia A, Dapavo P, Dattola A, De Simone C, Di Lernia V, Dini V, Donini M, Errichetti E, Esposito M, Fargnoli MC, Foti A, Fiorella C, Gargiulo L, Gisondi P, Guarneri C, Legori A, Lembo S, Loconsole F, Malagoli P, Marzano AV, Mercuri SR, Megna M, Micali G, Mortato E, Musumeci ML, Narcisi A, Offidani AM, Orsini D, Paolino G, Pellacani G, Peris K, Potenza C, Prignano F, Quaglino P, Ribero S, Richetta AG, Romanelli M, Rossi A, Strippoli D, Trovato E, Venturini M, Bianchi L. Campione E, et al. Among authors: rossi a. Pharmaceuticals (Basel). 2024 Oct 16;17(10):1378. doi: 10.3390/ph17101378. Pharmaceuticals (Basel). 2024. PMID: 39459016 Free PMC article.
Dupilumab versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison.
Ständer S, Pinter A, Hougeir FG, Guyot P, Xu Y, Praestgaard AH, Freemantle N, Rossi AB, Bégo-Le-Bagousse G, Wang Z, Noonan K, Bastian M. Ständer S, et al. Among authors: rossi ab. Dermatol Ther (Heidelb). 2025 Sep;15(9):2537-2551. doi: 10.1007/s13555-025-01479-y. Epub 2025 Jul 11. Dermatol Ther (Heidelb). 2025. PMID: 40646412 Free PMC article.
Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop.
Grünert SC, Derks TGJ, Mundy H, Dalton RN, Donadieu J, Hofbauer P, Jones N, Uçar SK, LaFreniere J, Contreras EL, Pendyal S, Rossi A, Schneider B, Spiegel R, Stepien KM, Wesol-Kucharska D, Veiga-da-Cunha M, Wortmann SB. Grünert SC, et al. Among authors: rossi a. Mol Genet Metab. 2024 Mar;141(3):108144. doi: 10.1016/j.ymgme.2024.108144. Epub 2024 Jan 17. Mol Genet Metab. 2024. PMID: 38277989 Free article. Review.
Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Chandraker A, Regmi A, Gohh R, Sharma A, Woodle ES, Ansari MJ, Nair V, Chen LX, Alhamad T, Norman S, Cibrik D, Singh M, Alper A, Jain D, Zaky Z, Knechtle S, Sharfuddin A, Gupta G, Lonze BE, Young JH, Adey D, Faravardeh A, Dadhania DM, Rossi AP, Florescu D, Cardarelli F, Ma J, Gilmore S, Vasileiou S, Jindra PT, Wojciechowski D. Chandraker A, et al. Among authors: rossi ap. J Am Soc Nephrol. 2024 May 1;35(5):618-629. doi: 10.1681/ASN.0000000000000329. Epub 2024 Mar 12. J Am Soc Nephrol. 2024. PMID: 38470444 Free PMC article. Clinical Trial.
7,514 results